<DOC>
	<DOCNO>NCT00932321</DOCNO>
	<brief_summary>This comparative study . The primary objective study assess efficacy low dose oral contraceptive prevention pregnancy . The secondary objective assess incidence intracyclic bleed norethindrone acetate/ethinyl estradiol ( NETA/EE ) administer 24 day NETA/EE administer 21 day ; assess safety tolerability product .</brief_summary>
	<brief_title>Study Safety Efficacy Oral Contraceptive</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy Women Age 1845 At risk pregnancy History regular cycle Contraindications use hormonal contraception Conditions affect absorption metabolism steroid hormone BMI &gt; 35</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Contraception</keyword>
</DOC>